Notice of Capital Markets Day
IXICO plc will host a Capital Markets Day for analysts and institutional investors on October 30, 2025, from 14:00 to 17:00 GMT at Cavendish Capital Markets' offices. The event will cover IXICO's growth strategy, future direction, neuroscience landscape trends, expansion opportunities, technology roadmap, and AI-driven precision medicine technology platform. Existing and prospective retail investors can join via a live webcast with the ability to submit questions. Registration for the webcast is available through Investor Meet Company.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
Notice of Capital
30 September 2025 IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development in neurological disorders, today announces it will be hosting a Capital Markets Day for analysts and institutional investors between 14:00 - 17:00 GMT on 30 October 2025 at the offices of Cavendish Capital Markets.
The event will provide the opportunity to hear from IXICO's CEO and strengthened senior management team, key customers and industry opinion leaders. The agenda will explore the Company's growth strategy and future direction, the neuroscience landscape trends and expansion opportunities for the Company, IXICO's technology roadmap and a detailed explanation of IXICO's AI-driven precision medicine technology platform
Existing and prospective retail investors are welcome to join via a live webcast. The facility to submit questions will be available on this platform.
To register your interest please contact Cavendish Capital Markets on +44 (0) 20 7220 0500 or via email ir@cavendish.com
To register for the live webcast investors can sign up to Investor Meet Company for free and add to meet IXICO PLC via: https://www.investormeetcompany.com/ixico-plc/register-investor
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.